Biological kits
Ended Awarded Last action
- Contract number
- 75N91025F00024
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $76,844
Award facts
- Contract value 100% obligated
- $76,843.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $76,844 |
About this award
The National Cancer Institute awarded a delivery order contract to Illumina, Inc. for biological kits valued at $76,843.62. The contract is a firm fixed price delivery order with an ultimate completion date of June 25, 2026, and no set-aside designation was utilized. Illumina, a leading biotechnology company headquartered in San Diego, California, specializes in genetic sequencing and genomic analysis technologies, supplying advanced DNA and RNA sequencing instruments, reagents, and consumables to federal agencies. The place of performance is located in San Diego, California, aligning with Illumina's headquarters location.
This delivery order supports the National Cancer Institute's research and diagnostic initiatives through the provision of specialized biological kits essential for genomic sequencing and analysis. Illumina has established a strong track record of providing comprehensive genomic sequencing solutions across multiple federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Agriculture. The award reflects Illumina's specialized technological capabilities and competitive positioning in the genomic technologies market, with the company's continued involvement in supporting federal scientific research through its advanced sequencing platforms and related consumables.
Quick answers
Who was awarded contract 75N91025F00024?
75N91025F00024 was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on June 26, 2025.
How much is contract 75N91025F00024 worth?
The government has obligated $76,844 on 75N91025F00024.
Is contract 75N91025F00024 an order under another contract?
Yes. 75N91025F00024 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N91025F00024 competed?
The extent of competition for 75N91025F00024 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award